Inventa Therapeutics

Inventa Therapeutics is a private biotechnology company based in Cambridge, Massachusetts, focused on the discovery and development of novel small molecule therapeutics for oncology. The company was founded and incubated by F-Prime Capital to address high unmet needs in cancer treatment by targeting specific biological pathways such as synthetic lethality and the DNA damage response. Inventa utilizes a proprietary drug discovery platform to identify and develop inhibitors against challenging, previously undruggable targets. Currently in the pre-clinical stage, the company is building a pipeline of precision medicines designed to provide transformative outcomes for cancer patients. Its leadership and strategic direction are closely integrated with the F-Prime Capital venture ecosystem.